GlassScriptPhysician profile
Navid Jalali
NPI 1154681955
$5,110.34
in general payments reported to CMS, 2019-2025
20 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,542 · 2020: $181 · 2021: $746 · 2022: $748 · 2023: $753 · 2024: $740 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,893.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $1,005.34 | 2019-2023 | Vumerity, Tysabri, Tecfidera |
| Teva Pharmaceuticals USA, INC. | $728.07 | 2019-2025 | Ajovy, Austedo Xr |
| Genentech, INC. | $626.79 | 2019-2024 | Ocrevus |
| Abbvie INC. | $563.01 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $340.07 | 2019-2023 | |
| Csl Behring | $277.58 | 2019-2021 | |
| Genentech USA, INC. | $245.28 | 2019 | |
| Ucb, INC. | $216.76 | 2024-2025 | Rystiggo, Zilbrysq |
| Tg Therapeutics, INC. | $207.85 | 2023-2024 | |
| Amgen INC. | $151.08 | 2019-2022 | |
| Genzyme Corporation | $123.96 | 2019 | |
| Celgene Corporation | $123.71 | 2021 | |
| Emd Serono, INC. | $118.11 | 2019 | |
| Argenx US, INC. | $89.36 | 2023 | Vyvgart |
| Biohaven Pharmaceutical Holding Company LTD. | $89.10 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $69.95 | 2025 | |
| Lilly USA, LLC | $59.26 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Mdd US Operations, LLC | $26.54 | 2019 | |
| Eisai INC. | $18.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navid Jalali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.